Liso-Cel Maintains Longer-Term Responses in Pretreated Relapsed/Refractory CLL/SLL
Tatyana Feldman, MD, highlights updated data for liso-cel in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Source: onclive.com
📰 Iso Cel News
Iso Cel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iso Cel . Real-time updates on events, politics, business and more.